W.W. Grainger Inc. Stock Outperforms Market Despite Losses On The Day

Spectrum Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

SPPI Spectrum Pharmaceuticals Inc

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

PEBO Peoples Bancorp Inc

BIOAF Bioasis Technologies Inc

NRGOF Newrange Gold Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

W.W. Grainger Inc. Stock Outperforms Market Despite Losses On The Day

4:58 pm ET November 2, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of W.W. Grainger Inc. (GWW) slid 1.47% to $583.98 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 2.50% to 3,759.69 and Dow Jones Industrial Average falling 1.55% to 32,147.76. The stock's fall snapped an eight-day winning streak. W.W. Grainger Inc. closed $11.41 below its 52-week high ($595.39), which the company reached on November 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Fastenal Co. (FAST) fell 1.68% to $48.01, Watsco Inc. Cl B (WSO) rose 7.24% to $284.97, and Snap-On Inc. (SNA) fell 0.83% to $220.03. Trading volume (342,357) remained 4,423 below its 50-day average volume of 346,780.

Data source: Dow Jones Market Data, FactSet. Data compiled November 2, 2022.

(END) Dow Jones Newswires

November 02, 2022 16:58 ET (20:58 GMT)